AuthorsCrosbie, Philip A J
Barber, Philip V
Harrison, Kathryn L
Gibbs, Alan R
Agius, Raymond M
Margison, Geoffrey P
Povey, Andrew C
AffiliationCancer Research UK Carcinogenesis Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, United Kingdom.
MetadataShow full item record
AbstractThe GSTM1 null genotype is associated with a small increased lung cancer risk when compared to controls with at least one copy of the GSTM1 gene. As two copies of the GSTM1 gene might provide more protection than a single copy, we have determined GSTM1 copy number in a lung cancer case-control study. Cases with incident lung cancer were identified through a Bronchoscopy Unit and two separate hospital based control groups with non-malignant disease were selected with one from the same Bronchoscopy Unit and the other from a chest clinic at the same hospital. Subjects with at least one GSTM1 copy had a decreased lung cancer risk whatever the control group: the odds ratio (95% CI), after adjustment for age, gender and smoking duration, was 0.64 (0.41-0.98) and 0.54 (0.32-0.91) with bronchoscopy and chest clinic controls, respectively. Lung cancer risk varied with GSTM1 copy number with chest clinic controls only: the OR was 0.56 (0.32-0.97) for one copy of the GSTM1 gene and with two copies 0.43 (0.15-1.22), a trend that was significant (p=0.02): with bronchoscopy controls the trend was not significant (p=0.07). Results then confirm that the presence of GSTM1 provides protection against the risk of lung cancer. In addition there is equivocal evidence that this protection varies with the number of gene copies.
CitationGSTM1 copy number and lung cancer risk. 2009, 664 (1-2):1-5 Mutat. Res.
- GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
- Authors: Schneider J, Bernges U, Philipp M, Woitowitz HJ
- Issue date: 2004 May 10
- Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
- Authors: Salagovic J, Kalina I, Stubna J, Habalová V, Hrivnák M, Valanský L, Kohút A, Biros E
- Issue date: 1998
- Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States).
- Authors: Kelsey KT, Spitz MR, Zuo ZF, Wiencke JK
- Issue date: 1997 Jul
- Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
- Authors: Nyberg F, Hou SM, Hemminki K, Lambert B, Pershagen G
- Issue date: 1998 Oct
- Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population.
- Authors: Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan SC, Ankathil R
- Issue date: 2005